Article Text
PostScript
Correspondence
Cardiac MRI as end point in clinical trials
Statistics from Altmetric.com
- MRI
- myocardial ischaemia and infarction (IHD)
- STEMI
- coronary angiography
- myocardial viability
- myocardial perfusion
- non-coronary intervention
- NSTEMI
- acute coronary syndrome
- coronary intervention
To the Editor We read with great interest the recent review article by Alex Pitcher and coworkers highlighting the role of cardiac MRI as a surrogate end point in clinical trials.1 The authors focus on vascular imaging, measurement of infarct size by late gadolinium enhancement (LGE) and measurement of ventricular volumes, …
Footnotes
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Linked Articles
- PostScript